These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38531691)

  • 21. Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis.
    McAleer MA; Jakasa I; Stefanovic N; McLean WHI; Kezic S; Irvine AD
    Br J Dermatol; 2021 Jul; 185(1):153-163. PubMed ID: 33269467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
    Simpson EL; Pink AE; Blauvelt A; Gooderham M; Armstrong AW; Worm M; Katoh N; Peris K; Puig L; Barbarot S; Mark T; Steffensen LA; Tindberg AM; Wollenberg A
    Am J Clin Dermatol; 2023 Nov; 24(6):939-952. PubMed ID: 37682422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of dupilumab on skin barrier function: A systematic review.
    Montero-Vilchez T; Sanabria-de-la-Torre R; Sanchez-Diaz M; Ureña-Paniego C; Molina-Leyva A; Arias-Santiago S
    J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1284-1292. PubMed ID: 36995919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis.
    Ferrucci S; Romagnuolo M; Maronese CA; Germiniasi F; Tavecchio S; Angileri L; Casazza G; Marzano AV; Genovese G
    Ther Adv Chronic Dis; 2021; 12():20406223211058332. PubMed ID: 34900210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.
    Beck LA; Cork MJ; Amagai M; De Benedetto A; Kabashima K; Hamilton JD; Rossi AB
    JID Innov; 2022 Sep; 2(5):100131. PubMed ID: 36059592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study.
    Montero-Vilchez T; Rodriguez-Pozo JA; Diaz-Calvillo P; Salazar-Nievas M; Tercedor-Sanchez J; Molina-Leyva A; Arias-Santiago S
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study.
    Cristaudo A; Pigliacelli F; Sperati F; Orsini D; Cameli N; Morrone A; Mariano M
    Skin Res Technol; 2021 Sep; 27(5):810-813. PubMed ID: 33651467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu.
    Toncic RJ; Jakasa I; Hadzavdic SL; Goorden SM; Vlugt KJG; Stet FS; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B; Kezic S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Either transepidermal water loss rates or stratum corneum hydration levels can predict quality of life in children with atopic dermatitis.
    Wang S; Shen C; Zhao M; Jiao L; Tian J; Wang Y; Ma L; Man MQ
    Pediatr Investig; 2021 Dec; 5(4):277-280. PubMed ID: 34938969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis.
    Haftek M; McAleer MA; Jakasa I; McLean WI; Kezic S; Irvine AD
    Wellcome Open Res; 2020; 5():97. PubMed ID: 32954014
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis.
    Woods MT; Brown PA; Baig-Lewis SF; Simpson EL
    J Drugs Dermatol; 2011 Feb; 10(2):171-6. PubMed ID: 21283922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tralokinumab in Atopic Dermatitis: A Profile of Its Use.
    Blair HA
    Clin Drug Investig; 2022 Apr; 42(4):365-374. PubMed ID: 35316850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies.
    Andersson AM; Sølberg J; Koch A; Skov L; Jakasa I; Kezic S; Thyssen JP
    Allergy; 2022 May; 77(5):1499-1509. PubMed ID: 34695223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement.
    Laudańska H; Reduta T; Szmitkowska D
    Rocz Akad Med Bialymst; 2003; 48():123-7. PubMed ID: 14737957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tralokinumab in atopic dermatitis.
    Wollenberg A; Weidinger S; Worm M; Bieber T
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1435-1442. PubMed ID: 34390128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin.
    Leung DYM; Bissonnette R; Kreimer S; Berdyshev E; Bafna S; Lyubchenko T; Richers BN; Garcia S; Ramirez-Gama M; Hall CF; Xiao O; Taylor P; Boguniewicz M; Levit NA; Agueusop I; Zhang A; Goleva E
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1421-1428. PubMed ID: 36958520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute irritant threshold correlates with barrier function, skin hydration and contact hypersensitivity in atopic dermatitis and rosacea.
    Darlenski R; Kazandjieva J; Tsankov N; Fluhr JW
    Exp Dermatol; 2013 Nov; 22(11):752-3. PubMed ID: 24112695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal Barrier Function and Skin Homeostasis in Atopic Dermatitis: The Impact of Age.
    Montero-Vilchez T; Cuenca-Barrales C; Rodriguez-Pozo JA; Diaz-Calvillo P; Tercedor-Sanchez J; Martinez-Lopez A; Molina-Leyva A; Arias-Santiago S
    Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis.
    Hulshof L; Hack DP; Hasnoe QCJ; Dontje B; Jakasa I; Riethmüller C; McLean WHI; van Aalderen WMC; Van't Land B; Kezic S; Sprikkelman AB; Middelkamp-Hup MA
    Br J Dermatol; 2019 Mar; 180(3):621-630. PubMed ID: 29989151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence.
    Quadri M; Lotti R; Bonzano L; Ciardo S; Guanti MB; Pellacani G; Pincelli C; Marconi A
    Skin Pharmacol Physiol; 2021; 34(1):8-18. PubMed ID: 33601378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.